tiprankstipranks
Plus Therapeutics, SpectronRx announce manufacturing partnership
PremiumThe FlyPlus Therapeutics, SpectronRx announce manufacturing partnership
20d ago
PSTV Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
PSTV Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
Plus Therapeutics files $100M mixed securities shelf
Premium
The Fly
Plus Therapeutics files $100M mixed securities shelf
2M ago
Plus Therapeutics presents FORESEE trial results
PremiumThe FlyPlus Therapeutics presents FORESEE trial results
4M ago
Plus Therapeutics presents interim ReSPECT-LM phase 1 data
Premium
The Fly
Plus Therapeutics presents interim ReSPECT-LM phase 1 data
4M ago
Is PSTV a Buy, Before Earnings?
Premium
Pre-Earnings
Is PSTV a Buy, Before Earnings?
4M ago
Plus Therapeutics Secures Loan to Terminate Debt and Regain Freedom
PremiumCompany AnnouncementsPlus Therapeutics Secures Loan to Terminate Debt and Regain Freedom
6M ago
Plus Therapeutics at Risk of Nasdaq Delisting: A Dive into Compliance Challenges and Potential Market Impact
Premium
Company Announcements
Plus Therapeutics at Risk of Nasdaq Delisting: A Dive into Compliance Challenges and Potential Market Impact
6M ago
Plus Therapeutics reports Q1 EPS (75c), consensus ($1.09)
Premium
The Fly
Plus Therapeutics reports Q1 EPS (75c), consensus ($1.09)
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100